RET and thyroid gland carcinoma: The oncogenes activated in thyroid carcinomas, RET/PTC, RAS, and BRAF, by triggering the MAPK cascade, can induce a proinflammatory transcriptional program in thyrocytes, which mainly includes cytokines, chemokines, and their receptors [14].